About Us
Careers
Partner with us
Forgot password?
Sign in
Login
Login
Email
Password
Forgot your password?
Join VuMedi
Select specialty
Your main specialty
Adult & Family Medicine
Allergy, Asthma, Immunology
Anesthesiology
Cardiology
Dental
Dermatology
Emergency Medicine
Endocrinology
Gastroenterology & Hepatology
General Surgery
Hematology & Oncology
Infectious Disease
Medical Genetics
Nephrology
Neurology
Neurosurgery
Obstetrics/Gynecology
Ophthalmology
Oral Maxillofacial
Orthopaedics
Otolaryngology
Pathology
Pediatrics
Physical Medicine & Rehab
Plastic Surgery
Podiatry
Preventive Medicine
Psychiatry
Pulmonology
Radiation Oncology
Radiology
Rheumatology
Urology
First name
Last name
Email
Choose Password
Playback speed
0.5x
0.75x
1x (Normal)
1.25x
1.5x
1.75x
2x
10 seconds
K
Resectable GEJ Adenocarcinoma: Case Presentation and Expert Panel Discussion
By
Integrity CE
FEATURING
Katherine Bever
,
Rahn Voong
,
Jonathan Hernandez
,
Samuel Klempner
By
Integrity CE
FEATURING
Katherine Bever
,
Rahn Voong
,
Jonathan Hernandez
,
Samuel Klempner
0 views
March 27, 2024
Comments
0
Login to view comments.
Click here to Login
Featured Video
15:07
Exelixis
Safety and Efficacy Data of a TKI Monotherapy in HCC
Feat.
J. Mizrahi
Featured Video
10:25
Exelixis
Explore the mechanism of Action of a TKI in HCC
Feat.
W. Keiser
Recommended
AUTOPLAY
ON
Related
Newest
57:44
Vogl, NY
Vogl,NY on How to Ask Good Questions at Medical Meetings
Feat.
S. Vogl
17:50
AdventHealth
Clinical Highlights From AACR 2024: Trials Evaluating Selected New T…
Feat.
G. Sonpavde
27:37
ASCO GI 2023 Conference Coverage
ASCO GI 2023 Expert Panel Discussion: Practice-Changing Updates
Feat.
N. Uboha,
A. Turk,
K. Spencer,
M. Cecchini
29:25
Young Chae
Hyperprogression in Cancer Treated With Immunotherapy
09:05
2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Summary: "Expert Panel Discussion on Upper-GI Cancer…
Feat.
N. Uboha,
A. Turk,
K. Spencer,
M. Cecchini
23:58
ASCO GI 2023 Conference Coverage
ASCO GI 2023 Key Studies
Feat.
R. Kim,
R. Mehta
27:12
Moffitt Cancer Center
Year in Review: Upper GI Cancers
Feat.
R. Kim,
R. Mehta
20:07
Insights from 2023 ASCO® Annual Meeting
ASCO® 2023 Summary: "GI Expert Panel Discussion on Key Trials I…
Feat.
Y. Janjigian,
S. Cytryn,
S. Maron
13:47
Aditya Shreenivas
Neoadjuvant IO in MSI-High GI Cancers: Special Focus on the DREAM GI…
Feat.
S. Chakrabarti
07:27
Jason Levy
Opus One: Final Results - RFA in Axial Skeleton
07:35
Insights from 2024 ASCO® GI Annual Meeting
ASCO® GI 2024 Summary: "Gastro-Esophageal Key Studies Including…
Feat.
R. Kim,
R. Mehta
09:42
Insights from 2024 ASCO® GI Annual Meeting
ASCO® GI 2024 Panel Discussion: "MATTERHORN & KEYNOTE-585 C…
Feat.
Y. Janjigian,
S. Cytryn,
S. Klempner
23:27
Insights from 2023 ESMO Annual Meeting
ESMO 2023 Summary: "GI Key Studies Including MATTERHORN & K…
Feat.
R. Kim,
R. Mehta
22:27
2024 ASCO® Annual Meeting Insights Hub
Developmental Therapeutics Highlights From ASCO® 2024
Feat.
G. Sonpavde
17:23
Insights from 2024 ASCO® GI Annual Meeting
ASCO® GI 2024 Summary: "Esophageal Squamous Cell Carcinoma Key …
Feat.
R. Kim,
R. Mehta
19:41
Balazs Halmos
How I Manage Immune Adverse Events in Solid Tumors
23:26
Yale Cancer Center
GI Cancer Updates: The Role of Surgery After Neoadjuvant Systemic Th…
Feat.
C. Balch
09:58
Elizabeth Smyth
Controversies in the Predictive Value of PD-L1 for Anti-PD-1 Benefit…
Feat.
R. Sundar
18:51
Hope for Stomach Cancer
1L Therapy for Stage 4 Gastroesophageal Cancers: The Role of Biomark…
Feat.
D. Catenacci
10:23
Insights from 2023 ESMO Annual Meeting
ESMO 2023 Insights: "Randomized Phase 3 GASTFOX Study - 5-fluor…
Feat.
A. Zaanan
